Related Experiment Video
Updated: Jul 21, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Assessing risk of major adverse cardiac event among COVID-19 patients using HEART score
Afrah Abdul Wahid Ali1, Quincy Tran2,3, Neeraja Murali2
1Department of Emergency Medicine, University of Maryland School of Medicine, 110 S Paca Street, 6th Floor, Suite 200, Baltimore, MD, 21201, USA. aaali@som.umaryland.edu.
Insights
The HEART score effectively predicts major adverse cardiac events (MACE) in chest pain patients with COVID-19, similar to those without the virus. This score remains a valuable tool for emergency department evaluations.
Area of Science:
- Cardiology
- Infectious Diseases
- Emergency Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is linked to cardiovascular complications.
- The applicability of the HEART score for chest pain patients with COVID-19 requires investigation.
Purpose of the Study:
- To assess the impact of COVID-19 co-infection on the HEART score's ability to predict 30-day major adverse cardiac events (MACE).
- To evaluate the HEART score's predictive performance in emergency department patients with chest pain and COVID-19.
Main Methods:
- A multicenter, retrospective observational study analyzing 46,210 adult patients with chest pain across 13 emergency departments.
- Patients were evaluated using the HEART score, with 30-day MACE (acute myocardial infarction, PCI, CABG, death) as the primary outcome.
- Receiver operating characteristic (ROC) curves assessed the HEART score's sensitivity and specificity in COVID-19 co-infected patients.
Main Results:
- Out of 46,210 patients, 327 (0.7%) had COVID-19. COVID-19 patients had a slightly higher mean HEART score (3.3 vs. 3.1).
- The rate of 30-day MACE was similar between COVID-19 positive (0.6%) and negative (1.1%) groups.
- The HEART score demonstrated strong predictive capability for MACE in COVID-19 patients (AUROC 0.99), comparable to the control group (AUROC 0.78).
Conclusions:
- The HEART score retains its predictive value for 30-day MACE in emergency department patients with chest pain and concurrent COVID-19 infection.
- Further research with larger COVID-19 cohorts is needed to validate these findings.
- The HEART score remains a relevant tool for risk stratification in chest pain presentations, even with COVID-19 co-infection.
Abstract:
Coronavirus disease 2019 (COVID-19) is known to be associated with cardiovascular complications, but whether the current validated HEART score for chest pain is still applicable for these patients is unknown. This study aims to identify the impact and association of COVID-19 co-infection in patients presenting with chest pain and a calculated HEART score to the emergency departments (ED) with 30-day of major adverse cardiac event (MACE). This is a multicenter, retrospective observational study that included adult (age ≥ 18 years) patients visiting 13 different EDs with chest pain and evaluated using a HEART score. The primary outcome was the percentage of 30-day MACE, which included acute myocardial infarction, emergency percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), or death among patients who presented with chest pain and had COVID-19 co-infection. The sensitivity and specificity of the HEART score among COVID-19 co-infection for MACE were assessed by the receiver operating curve (ROC). We analyzed records of 46,210 eligible patients, in which 327 (0.7%) patients were identified as infected with COVID-19. Patients with COVID-19 had higher mean total HEART score of 3.3 (1.7), compared to patients who did not have COVID-19 (3.1, SD 1.8, P = 0.048). The rate of MACE was similar between both groups. There were only 2 (0.6%) COVID-19 patients who had MACE, compared to 504 (1.1%) patients in control group. Total HEART score was associated with an area under the ROC (AUROC) of 0.99, while the control group's was 0.78. History was associated with high AUROC in both COVID-19 (0.74) and control groups (0.76). Older age in COVID-19 had higher AUROC (0.89) than control patients (0.63). Among patients presenting to the ED with chest pain and having COVID-19 infection, HEART score had predictive capability for MACE, similar to patients without COVID-19 infection. Further studies with more COVID-19 patients are still necessary to confirm our observation.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:03Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
Published on: December 11, 2019
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Acute Coronary Syndrome I: Introduction
Heart Failure V: Medical Management
Coronary Artery Disease IV: Preventive Measures